Figure 4.
TAK1 inhibitors in the ATP binding pocket of TAK1. (a) Overlay of covalent, type I, and type II inhibitors in the TAK1 ATP binding pocket. (b) Key interacting residues of the covalent TAK1 inhibitor 5Z-7-Oxozeanol (PDB 4GS6), type I ABC-FP (PDB 4L53), type 1.5 takinib (PDB 5V5N) and type II NG-25 (PDB 4O91).